Vapotherm
Device
Vapotherm Inc
Total Payments
$43,202
Transactions
2
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2023 | $43,202 | 2 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $43,202 | 2 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Hypercapnia Clinical Efficacy by NIPPV v HVNI: A Randomized Control Trial in the Stabilization of Acute Hypercarbic Respiratory Failure (HYPERACT) | Vapotherm Inc | $43,202 | 0 |
Top Doctors Receiving Payments for Vapotherm
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Washington, DC | $43,202 | 2 |
Ad
Manufacturing Companies
- Vapotherm Inc $43,202
Product Information
- Type Device
- Total Payments $43,202
- Total Doctors 0
- Transactions 2
About Vapotherm
Vapotherm is a device associated with $43,202 in payments to 0 healthcare providers, recorded across 2 transactions in the CMS Open Payments database. The primary manufacturer is Vapotherm Inc.
Payment data is available from 2023 to 2023. In 2023, $43,202 was paid across 2 transactions to 0 doctors.
The most common payment nature for Vapotherm is "Unspecified" ($43,202, 100.0% of total).
Vapotherm is associated with 1 research study, including "Hypercapnia Clinical Efficacy by NIPPV v HVNI: A Randomized Control Trial in the Stabilization of Acute Hypercarbic Respiratory Failure (HYPERACT)" ($43,202).